Chowdary, Pratima
Article History
Received: 26 September 2018
Accepted: 4 October 2018
First Online: 9 October 2018
Compliance with ethical standards
:
: PC has worked as an investigator on the anti-TFPI mAb for Novo Nordisk and Bayer; has received honoraria from Baxalta/Shire, Biogen Idec, CSL Behring, Novo Nordisk, Pfizer, Roche, and Sobi; has served on advisory boards for Bayer, Baxalta/Shire, Biogen Idec, CSL Behring, Chugai, Freeline, Novo Nordisk, Pfizer, Roche, and Sobi; and has received research funding from Bayer, CSL Behring, Novo Nordisk, Pfizer, and SOBI.